• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2016年世界卫生组织分类后的临时肾细胞癌亚组]

[Provisional renal cell carcinoma subsets following the 2016 WHO classification].

作者信息

Jenei Alex, Hes Ondrej, Kuthi Levente

机构信息

Patológiai Intézet, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Állomás u 1., 6725.

Charles University Hospital Plzeň.

出版信息

Orv Hetil. 2020 Jan;161(3):83-94. doi: 10.1556/650.2020.31654.

DOI:10.1556/650.2020.31654
PMID:31928058
Abstract

Renal cell carcinoma (RCC) represents a heterogenous group of malignant tumors that originate from the kidney parenchyma. The different entities have their own specific epidemiological, morphological, immunohistochemical, genetic and clinical characteristics. The new WHO classification of renal tumors was published in 2016, and it takes all of these features together into account. Although in the past three years, several emerging subtypes have been described, these are not yet included in the current classification. In this review paper, these entities are summarized in details including the following emerging subsets: thyroid-like follicular carcinoma, rearrangement-associated RCC, renal cell carcinoma with prominent smooth muscle stroma, fumarate hydratase-deficient RCC, biphasic squamoid papillary RCC, eosinophilic solid and cystic RCC, atrophic kidney-like RCC, clear cell RCC with giant cells and emperipolesis, Warthin-like papillary RCC, low-grade oncocytic renal tumor (CD117-negative; CK7-positive), high-grade oncocytic renal tumor, -mutated RCC and chromophobe RCC with neuroendocrine features. These entities are mostly diagnosed as RCC unclassified. The aim of this study is to introduce these subsets to the Hungarian pathologists, oncologists and urologists, to prompt diagnostic accuracy and to facilitate a collection along with a consecutive analysis of these cases. Orv Hetil. 2020; 161(3): 83-94.

摘要

肾细胞癌(RCC)是一组起源于肾实质的异质性恶性肿瘤。不同的实体有其自身特定的流行病学、形态学、免疫组化、遗传学和临床特征。2016年发布了新的WHO肾肿瘤分类,该分类综合考虑了所有这些特征。尽管在过去三年中已经描述了几种新出现的亚型,但目前的分类中尚未包括这些亚型。在这篇综述论文中,详细总结了这些实体,包括以下新出现的亚组:甲状腺样滤泡癌、重排相关肾细胞癌、具有显著平滑肌间质的肾细胞癌、延胡索酸水合酶缺陷型肾细胞癌、双相鳞状乳头肾细胞癌、嗜酸性实性和囊性肾细胞癌、萎缩肾样肾细胞癌、具有巨细胞和血细胞吞噬现象的透明细胞肾细胞癌、沃辛样乳头状肾细胞癌、低级别嗜酸性肾肿瘤(CD117阴性;CK7阳性)、高级别嗜酸性肾肿瘤、-突变肾细胞癌和具有神经内分泌特征的嫌色肾细胞癌。这些实体大多被诊断为未分类的肾细胞癌。本研究的目的是向匈牙利病理学家、肿瘤学家和泌尿科医生介绍这些亚组,提高诊断准确性,并促进对这些病例的收集及后续分析。《匈牙利医学周报》。2020年;161(3): 83-94。

相似文献

1
[Provisional renal cell carcinoma subsets following the 2016 WHO classification].[2016年世界卫生组织分类后的临时肾细胞癌亚组]
Orv Hetil. 2020 Jan;161(3):83-94. doi: 10.1556/650.2020.31654.
2
New and emerging renal entities: a perspective post-WHO 2016 classification.新出现的肾脏实体:世卫组织 2016 年后分类的观点。
Histopathology. 2019 Jan;74(1):31-59. doi: 10.1111/his.13727.
3
New insights in the new WHO classification of adult renal tumors.世界卫生组织成人肾肿瘤新分类中的新见解。
Cesk Patol. 2022 Fall;67(4):187-191.
4
Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.肾细胞癌的形态学、分子学及分类学演变:基于2016年世界卫生组织分类更新的概念性观点
Arch Pathol Lab Med. 2016 Oct;140(10):1026-37. doi: 10.5858/arpa.2016-0218-RA.
5
Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma.当代成人未分类肾细胞癌的特征描述和再分类。
Am J Surg Pathol. 2021 Apr 1;45(4):450-462. doi: 10.1097/PAS.0000000000001629.
6
The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges.2022 年版世界卫生组织泌尿系统和男性生殖器官肿瘤分类:进展与挑战。
Hum Pathol. 2023 Jun;136:123-143. doi: 10.1016/j.humpath.2022.08.006. Epub 2022 Sep 6.
7
[Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].[富马酸水合酶缺陷型肾细胞癌的临床病理特征]
Zhonghua Bing Li Xue Za Zhi. 2019 Feb 8;48(2):120-126. doi: 10.3760/cma.j.issn.0529-5807.2019.02.009.
8
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.新型、新兴和暂定的肾脏实体:泌尿生殖系统病理学学会(GUPS)关于肾脏肿瘤的更新。
Mod Pathol. 2021 Jun;34(6):1167-1184. doi: 10.1038/s41379-021-00737-6. Epub 2021 Feb 1.
9
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.世界卫生组织 2022 年版乳头状和嫌色细胞肾细胞癌图谱。
Histopathology. 2022 Oct;81(4):426-438. doi: 10.1111/his.14700. Epub 2022 Jun 10.
10
Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.根据2016年世界卫生组织肾肿瘤分类诊断的肾细胞癌亚型的预后因素:一项涉及928例患者的研究
Pathol Oncol Res. 2017 Jul;23(3):689-698. doi: 10.1007/s12253-016-0179-x. Epub 2016 Dec 28.

引用本文的文献

1
Prognostic values of blood urea nitrogen/creatinine and cystatin C in patients with radical nephrectomy for renal cell carcinoma.肾细胞癌根治性肾切除患者血尿素氮/肌酐及胱抑素C的预后价值
J Med Biochem. 2024 Jun 15;43(4):436-444. doi: 10.5937/jomb0-45664.
2
Angiomyolipoma of the kidney-Clinicopathological analysis of 52 cases.肾脏血管平滑肌脂肪瘤—52 例临床病理分析。
Pathol Oncol Res. 2023 Jan 9;28:1610831. doi: 10.3389/pore.2022.1610831. eCollection 2022.